Overview
The purpose of this study is to investigate the safety and tolerability of Lu AG06479 and what the body does to Lu AG06479 after swallowing single doses of the drug
Description
Part A: randomized, sequential
Part B: open-label, cross-over
Eligibility
Inclusion Criteria:
- Healthy, young, non-smoking men, weight 60 kg, and a body mass index (BMI) 18.5 kg/m2 and 30 kg/m2 at the Screening Visit.
Other in- and exclusion criteria may apply